Feuerhake, Cord

Efficacy, tolerability and safety of the fixed combination of bimatoprost 0.03% and timolol 0.5% in a broad patient population: multicenter, open-label observational study. [electronic resource] - Current medical research and opinion Apr 2009 - 1037-43 p. digital

Publication Type: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't

1473-4877

10.1185/03007990902816947 doi


Amides--adverse effects
Antihypertensive Agents--adverse effects
Bimatoprost
Cloprostenol--adverse effects
Drug Administration Schedule
Drug Therapy, Combination
Female
Glaucoma, Open-Angle--drug therapy
Humans
Intraocular Pressure--drug effects
Male
Ocular Hypertension--drug therapy
Optic Disk--drug effects
Timolol--adverse effects
Visual Fields--drug effects